Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-22

FDA Approved: DESLORATADINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for desloratadine, a generic antihistamine used to treat allergy symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

SUPPL AP for DESLORATADINE (DESLORATADINE)